Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
85.5M
-
Shares change
-
+2.56M
-
Total reported value, excl. options
-
$2.65B
-
Value change
-
+$85.2M
-
Put/Call ratio
-
0.22
-
Number of buys
-
89
-
Number of sells
-
-91
-
Price
-
$31.00
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q3 2021
244 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q3 2021.
Evolent Health, Inc. - Class A Common Stock (EVH) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85.5M shares
of 112M outstanding shares and own 76.58% of the company stock.
Largest 10 shareholders include Engaged Capital LLC (7.89M shares), VANGUARD GROUP INC (7.37M shares), JPMORGAN CHASE & CO (6.21M shares), BlackRock Inc. (5.6M shares), FMR LLC (5.15M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (4.81M shares), CREDIT SUISSE AG/ (3.81M shares), DIMENSIONAL FUND ADVISORS LP (3.31M shares), Bellevue Group AG (3.03M shares), and BLAIR WILLIAM & CO/IL (2.56M shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.